Rising Mental Disorder Cases Drive Expansion Of The Generalized Anxiety Disorder Market: A Significant Driver Propelling The Generalized Anxiety Disorder Market In 2025

The Generalized Anxiety Disorder Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].

What Is the Generalized Anxiety Disorder Market Size and Projected Growth Rate?
The market size for generalized anxiety disorder has seen a stable growth in the past few years. The market is expected to expand from $7.76 billion in 2024 to $8.01 billion in 2025, with a compound annual growth rate (CAGR) of 3.2%. Factors such as increased mindfulness about mental health, advancements in the pharmaceutical industry, the presence of cognitive-behavioral therapy (CBT), and shifts towards stressful lifestyle have contributed to the observed growth in the historical period.

In the coming years, the market size for generalized anxiety disorder is predicted to experience consistent growth. The market is projected to expand to $9.32 billion by 2029, with a compounded annual growth rate (CAGR) of 3.9%. The anticipated growth in this forecast period can be credited to factors like digital solutions for mental health, genetic studies, comprehensive care models, and worldwide awareness of mental health issues. Key trends during this period are expected to be comprehensive methods, cultural proficiency, early preventive measures, and the application of artificial intelligence (AI) in disease diagnosis.

Purchase the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=13039

What Are the Major Segments in the Generalized Anxiety Disorder Market?
The generalized anxiety disorder market covered in this report is segmented -

1) By Type: Panic Disorder, Agoraphobia, Generalized Anxiety, Social Anxiety, Specific Phobia, Other Types
2) By Therapies: Interpersonal Therapy, Behavior Therapy, Cognitive Behavioral Therapy, Mindfulness Based Cognitive Therapy
3) By Device: Deep Brain Stimulation, Electroconvulsive Therapy, Transcranial Magnetic Stimulation, Vagus Nerve Stimulation
4) By End-User: Hospitals, Homecare, Specialty Clinics, Other End-Users

Subsegments:
1) By Panic Disorder: Recurrent Panic Attacks, Unexpected Panic Attacks
2) By Agoraphobia: Situational Phobia, Open Spaces Anxiety
3) By Generalized Anxiety: Chronic Worry, Excessive Anxiety
4) By Social Anxiety: Performance Anxiety, Interaction Anxiety
5) By Specific Phobia: Animal Phobia, Environmental Phobia, Situational Phobia
6) Other Type: Separation Anxiety Disorder, Selective Mutism, Post-Traumatic Stress Disorder (PTSD)

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=13039&type=smp

What Are The Driving Generalized Anxiety Disorder Market Evolution?
The escalation in the prevalence of mental illnesses in the medical sector is a significant contributor to the expansion of the generalized anxiety disorder market. Mental disorders, which can manifest as a myriad of conditions affecting one's thought processes, feelings, actions, and mental health in general, often coexist with generalized anxiety disorder. These might include phobias, panic disorder, post-traumatic stress disorder (PTSD), and obsessive-compulsive disorder (OCD). It is essential to manage these to maintain healthy relationships and enhance life quality. For example, based on the Stress in America 2023 survey published by the American Psychological Association, there was a significant surge in mental health diagnoses among adults aged 35 to 44 in November 2023. Compared to 31%, 45% reported suffering from a mental illness in 2023. Nonetheless, mental illnesses were most prevalent among 18 to 34-year-olds, with 50% reporting mental health issues in 2023. This increase in mental health cases is projected to spur the growth of the generalized anxiety disorder market. The growth of the generalized anxiety disorder market is further bolstered by increasing government efforts. A government initiative refers to any plan or action initiated by a governing body, funded through various means such as taxes, grants, and donations, to address a specific issue or problem. Such initiatives pertaining to generalized anxiety disorder often involve funding research to better comprehend the causes and treatments of the condition and to devise new, more effective methods to assist those with this disorder. In March 2022, for example, the Department of Health and Human Services in the U.S. announced potential funding of nearly $35 million aimed at enhancing and expanding community mental health services and suicide prevention strategies for children and young people across the country. Therefore, these escalating government initiatives are anticipated to fuel the growth of the generalized anxiety disorder market.

Which Firms Dominate The Generalized Anxiety Disorder Market Segments?
Major companies operating in the generalized anxiety disorder market are Alkermes PLC, Pfizer Inc., F. Hoffmann-La Roche AG, Sanofi SA, Bristol-Myers Squibb, GlaxoSmithKline PLC, AstraZeneca PLC, Abbott Laboratories, 3M Company, Boehringer Ingelheim International GmbH, Johnson And Johnson Private Limited, Adobe Inc., Baxter International Inc., Teva Pharmaceutical Industries Ltd., Otsuka Holdings Co. Ltd., Mylan N.V., Sumitomo Pharma Co. Ltd., Jazz Pharmaceuticals PLC, Forest Laboratories Inc., H. Lundbeck A/S, Shionogi and Company, Neurocrine Biosciences Inc., Actavis Pharmaceutical Company, Eli Lilly and Company, Noven Pharmaceuticals Inc., Mind Medicine Inc., Sage Therapeutics Inc., Bionomics Ltd., Recordati Rare Diseases SARL, VistaGen Therapeutics Inc.

What Trends Are Expected to Dominate the Generalized Anxiety Disorder Market in the Next 5 Years?
Leading firms within the generalized anxiety disorder sector are focusing on the development and approval of cutting-edge drugs such as MM-120, striving to fulfill the needs of their current clientele more effectively. MM-120, among other innovative medications, is designed to enhance both the handling and outcome of this psychological disorder. For example, Mind Medicine Inc., a psychedelic medicine biotech company based in the US, gained approval in January 2022 for the Investigational New Drug (IND) application by the U.S. Food and Drug Administration (FDA). This approval allows the company to proceed with its phase IIb dose-optimization trial of MM-120 for treating generalized anxiety disorder (GAD). MM-120 is a tiny molecule that acts as a partial agonist of the 5-HT2A receptor, a receptor that plays a crucial role in the regulation of mood, anxiety, and perception. Furthermore, MM-120 is believed to function by boosting serotonin levels in the brain, possibly establishing a precedent for the development of other psychedelic compounds aimed at treating mental health conditions.

Get the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/report/generalized-anxiety-disorder-global-market-report

Which Is The Largest Region In The Generalized Anxiety Disorder Market?
North America was the largest region in the generalized anxiety disorder market in 2024. The regions covered in generalized anxiety disorder market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

Frequently Asked Questions:
1. What Is the Market Size and Growth Rate of the Generalized Anxiety Disorder Market?
2. What is the CAGR expected in the Generalized Anxiety Disorder Market?
3. What Are the Key Innovations Transforming the Generalized Anxiety Disorder Industry?
4. Which Region Is Leading the Generalized Anxiety Disorder Market?

Why This Report Matters:

Competitive overview: This report analyzes the competitive landscape of the 3D imaging software market, evaluating key players on market share, revenue, and growth factors.

Informed Decisions: Understand key strategies related to products, segmentation, and industry trends.

Efficient Research: Quickly identify market growth, leading players, and major segments.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.